Examining the Impact of Connected Devices on GLP-1 Therapy
In a March 2024 survey, Withings Health Solutions asked their database of device users about their experience with GLP-1 treatments and the biomarkers they’ve been monitoring throughout their health journey, garnering responses from 2352 participants.
Improving Program Adherence and Operational Efficiency to Help Drive Target Weight Loss for a Diabetes Prevention Program
HabitNu partnered with Withings Health Solutions to provide the Wifi-based Body scale, along with the Withings HealthMate app that syncs seamlessly with HabitNu’s app.
Pioneering Real Change in Diabetes Care
Up to 70% of people with diabetes will be affected by diabetic peripheral neuropathy, and nearly half have no symptoms to alert them that it’s happening. This often silent condition increases the risk of foot ulcers and potential amputations. Patients with diabetic foot ulcers have a two-fold greater increase in mortality.